SREBF1 and diabetes mellitus: Diabetes also triggers renal steatosis and lipotoxicity via inhibiting the peroxisome proliferator-activated receptor (PPAR)-α and -γ lipolytic [8,9], whilst enhancing the sterol regulatory element-binding protein-1 (SREBP-1) lipogenic molecules [10,11].